45
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis

, , , , , , & show all
Pages 973-984 | Published online: 17 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Giusi Santangelo, Giuseppe Caruso, Innocenza Palaia, Federica Tomao, Giorgia Perniola, Violante Di Donato, Margherita Fischetti, Ludovico Muzii & Pierluigi Benedetti Panici. (2020) The emerging role of precision medicine in the treatment of ovarian cancer. Expert Review of Precision Medicine and Drug Development 5:4, pages 283-297.
Read now

Articles from other publishers (11)

Ehsan Sadeghi Ghasemabad, Mahdi Mirhadi, Zahra Goorkani Zarandi & Ahmad Mahdian Parrany. (2023) Adaptive fuzzy control of drug delivery in cancer treatment using combination of chemotherapy and antiangiogenic therapy. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 237:3, pages 419-432.
Crossref
Chunmei Zhang & Wancheng Zhao. (2022) The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis. Journal of Ovarian Research 15:1.
Crossref
Shupei Zhang, Diling Pan, Shaoyu Zhang, Qiumei Wu, Lan Zhen, Shihuang Liu, Jingjing Chen, Rong Lin, Qiuhua Hong, Xiangqin Zheng & Huan Yi. (2022) Exosomal miR-543 Inhibits the Proliferation of Ovarian Cancer by Targeting IGF2. Journal of Immunology Research 2022, pages 1-18.
Crossref
Michael Saerens, Emiel A. De Jaeghere, Heini Kanervo, Nele Vandemaele, Hannelore Denys & Eline Naert. (2021) Risk of Thrombo-Embolic Events in Ovarian Cancer: Does Bevacizumab Tilt the Scale? A Systematic Review and Meta-Analysis. Cancers 13:18, pages 4603.
Crossref
Ezgi Guler, Daniel A. Smith, Bhanusupriya Somarouthu, Rahul Gujrathi, Nikhil H. Ramaiya & Sree Harsha Tirumani. (2019) Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer. Abdominal Radiology 45:3, pages 828-841.
Crossref
Karl Reinhard Aigner, Emir Selak, Sabine Gailhofer & Kornelia Aigner. (2019) Hypoxic Isolated Abdominal Perfusion (HAP) chemotherapy for non-operable advanced staged ovarian cancer with peritoneal carcinosis: an experience in 45 platinum-refractory ovarian cancer patients. Indian Journal of Surgical Oncology 10:3, pages 506-514.
Crossref
Vasilios Pergialiotis, Anastasia Androutsou, Eleni Papoutsi, Ioannis Bellos, Nikolaos Thomakos, Dimitrios Haidopoulos & Alexandros Rodolakis. (2019) Survival outcomes of ovarian cancer patients treated with secondary cytoreductive surgery for isolated lymph node recurrence: A systematic review of the literature. International Journal of Surgery 69, pages 61-66.
Crossref
Syama Krishnapriya, Chirukandath Sidhanth, Pacharla Manasa, Smarakan Sneha, Sadhanandhan Bindhya, Rohit P. Nagare, Balaji Ramachandran, Pushpa Vishwanathan, Kanchan Murhekar, Sundersingh Shirley & Trivadi Sundaram Ganesan. (2019) Cancer stem cells contribute to angiogenesis and lymphangiogenesis in serous adenocarcinoma of the ovary. Angiogenesis 22:3, pages 441-455.
Crossref
Rachel Glincher, Anita P. Price, Michael P. LaQuaglia, Brian H. Kushner & Shakeel Modak. (2018) Bevacizumab-associated Bowel Microperforation in a Patient With Neuroblastoma. Journal of Pediatric Hematology/Oncology 40:6, pages e394-e396.
Crossref
Alexander J. Cortez, Patrycja Tudrej, Katarzyna A. Kujawa & Katarzyna M. Lisowska. (2017) Advances in ovarian cancer therapy. Cancer Chemotherapy and Pharmacology 81:1, pages 17-38.
Crossref
Caroline Lum & Christopher B. Steer. (2017) Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients. Drugs & Aging 34:11, pages 821-831.
Crossref